UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ)
$68.07 1.02 (1.5213%)
Analysed UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ) News Sources
Utah Medical's Q4 Earnings Hurt by OEM Decline, Fall Y/Y
04-02-2026
yahoo.com
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.31
08-02-2026
yahoo.com
Top Research Reports for American Express, Intuitive Surgical & Shopify
01-04-2026
yahoo.com
The Zacks Analyst Blog American Express, Intuitive Surgical, Shopify and Utah Medical Products
02-04-2026
yahoo.com
Utah Medical Gains 32% in a Year: Should You Buy the Stock?
16-04-2026
yahoo.com
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026
23-04-2026
yahoo.com
Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs
29-04-2026
yahoo.com
Utah Medical Products, Inc. Announces Quarterly Dividend
05-05-2026
yahoo.com
Top Analyst Reports for Berkshire Hathaway, Eli Lilly & Walmart
04-06-2026
yahoo.com
The Zacks Analyst Blog Highlights Berkshire, Eli Lilly, Walmart, Universal Health Realty Income and Utah
05-06-2026
yahoo.com
What is the current price of UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ)?
The current price of UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ) is $68.07.
UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ) since the previous trading day is $1.02.
UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ) since the previous trading day is 1.5213%.
What is the most recent average sentiment score for UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ)?
The most recent average sentiment score for UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ) is 55 out of 100.
What is the most recent average sentiment for UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ)?
The most recent sentiment for UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ) is .
SEC-8K** Filing Available For UTAH MEDICAL PRODUCTS INC (UTMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.